DPP4 and coronary artery disorder: Regarding the medication prescriptions, the severe CHD group showed a higher ratio of dipeptidyl peptidase-4 inhibitor application compared to the mild CHD group (ASD = 0.3872), while the applications of other medications did not show a significant difference between the two groups due to the PSM approach (all ASD < 0.1000) (Table 1).